Drugs / EV-077
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01551381 | Jan → May 2012 | type 2 diabetes mellitus | Evolva SA | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EV-077 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01551381 ↗ |
| Route | Oral | “twice daily oral administration” NCT01551381 ↗ |